何志伟;喻超;田舍;陈世裕;张乙凡;潘耀振;孙诚谊;
HE Zhiwei;YU Chao;TIAN She;CHEN Shiyu;ZHANG Yifan;PAN Yaozhen;SUN Chengyi;Department of Hepatobiliary Surgery,the Affiliated Hospital of Guizhou Medical University;Key Laboratory of Liver,Gallbladder,Pancreas and Spleen,Guizhou Medical University;

• 1:贵州医科大学附院肝胆外科
• 2:贵州医科大学肝胆胰脾重点实验室

摘要(Abstract)：

目的:过表达microRNA-137(miR-137)对体外人胰腺癌增殖能力的影响及其机制初探。方法:将胰腺癌PANC-1和As PC细胞分为miR-137 mimics转染组和对照组,并通过qRT-RCR检测转染效率;利用流式细胞仪检测细胞凋亡率和周期阻滞变化,CCK-8实验、平板克隆实验检测miR-137对胰腺癌细胞增殖能力的影响,qRT-RCR、Western blot等实验检测miR-137对PTN的mRNA及蛋白表达的影响。结果:上调miR-137表达后,PANC-1、As PC胰腺癌细胞凋亡率增加(P<0.05)、周期阻滞于G1期比例增加(P<0.05);CCK8及平板克隆实验结果均显示过表达miR-137后,胰腺癌细胞增殖能力降低PTN表达显著下调。结论:miR-137在胰腺癌细胞中的表达水平影响抑制胰腺癌的增殖能力,其机制可能与抑制PTN的表达有关。
Objective: To investigate the effect of miR-137 on the proliferation of pancreatic cancer cells and to study the mechanism. Methods: The pancreatic cancer PANC-1 and As PC cells were divided into miR-137 mimics transfection group and control group,and the transfection efficiency was detected by qRT-RCR. Flow cytometry was used to detect the apoptosis rate and the changes of cell cycle arrest,The effect of miR-137 on the proliferation of pancreatic cancer cells was detected by CCK-8 assay and plate cloning assay. The effects of miR-137 on the mRNA and protein expression levels of PTN were measured by PCR and Western blot. Results: miR-137 up-expression effectively inhibited the apoptosis rate and controled cell cycle arrest of pancreatic cancer cell( P < 0. 05). The proliferation ability of PANC-1 and As PC cells decreased significantly after over-expression of miR-137( P < 0. 05).Meanwhile miR-137 over-expression decreased the expression level of PTN( P < 0. 05). Conclusion:miR-137 inhibits the proliferation of pancreatic cancer cells possibly through down-regulating the PTN expression level.

关键词(KeyWords)： microRNA-137;胰腺肿瘤;增殖;转染;流式细胞术
microRNA-137;pancreatic cancer;proliferation;transfection;flow cytometry

Abstract:

Keywords:

基金项目(Foundation): 国家国际科技合作专项资助项目(2014DFA31420);; 国家自然科学基金资助项目(81560477);; 贵州省科学技术厅-贵州医科大学附属医院联合基金[黔科合LH字(2016)7229号];; 贵州省第四批人才基地基金资助[黔省专合字(2012)94号];; 贵州省科学技术厅-贵阳医学院院士工作站肝胆外科分站[黔科合院士站(2015)4013];; 贵州医科大学肝胆胰脾重点实验室项目资助

作者(Author): 何志伟;喻超;田舍;陈世裕;张乙凡;潘耀振;孙诚谊;
HE Zhiwei;YU Chao;TIAN She;CHEN Shiyu;ZHANG Yifan;PAN Yaozhen;SUN Chengyi;Department of Hepatobiliary Surgery,the Affiliated Hospital of Guizhou Medical University;Key Laboratory of Liver,Gallbladder,Pancreas and Spleen,Guizhou Medical University;

Email:

DOI: 10.19367/j.cnki.1000-2707.2017.11.002

参考文献(References)：

• [1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2015[J].CA Cancer J Clin,2015(1):5-29.
• [2]Hu B,Shi C,Jiang HX,et al.Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis[J].Medicine(Baltimore),2017(42):e8261.
• [3]Neault M,Mallette FA,Richard S.miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells[J].Cell Rep,2016(8):1966-1978.
• [4]Zhao LC,Shen BY,Deng XX,et al.TMEM45B promotes proliferation,invasion and migration and inhibits apoptosis in pancreatic cancer cells[J].Mol Biosyst,2016(6):1860-1870.
• [5]Sun B,Li J,Shao D,et al.Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals[J].Onco Targets Ther,2015(8):735-744.
• [6]Yao J,Zhang M,Ma QY,et al.PAd-shRNA-PTN reduces pleiotrophin of pancreatic cancer cells and inhibits neurite outgrowth of DRG[J].World J Gastroenterol,2011(21):2667-2673.
• [7]Xiao J,Peng F,Yu C,et al.microRNA-137 modulates pancreatic cancer cells tumor growth,invasion and sensitivity to chemotherapy[J].Int J Clin Exp Pathol,2014(11):7442-7450.
• [8]Siegel RL,Fedewa SA,Miller KD,et al.Cancer statistics for Hispanics/Latinos,2015[J].CA Cancer J Clin,2015(6):457-480.
• [9]Tian S,Guo X,Yu C,et al.miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1[J].Oncotarget,2017(7):11071-11082.
• [10]Yao J,Ma QY,Wang LC,et al.Construction of the recombinant adenovirus mediated shRNA to silence PTN in pancreatic carcinoma and the effect of DRGn on neurite in vitro[J].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2007(9):797-800.
• [11]Qin C,Huang RY,Wang ZX.Potential role of miR-100 in cancer diagnosis,prognosis,and therapy[J].Tumour Biol,2015(3):1403-1409.
• [12]Gu J,Wang Y,Wu X.MicroRNA in the pathogenesis and prognosis of esophageal cancer[J].Curr Pharm Des,2013(7):1292-1300.
• [13]Chen Q,Chen X,Zhang M,et al.miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42[J].Dig Dis Sci,2011(7):2009-2016.
• [14]Wu Z,Sun H,Zeng W,et al.Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1[J].PLo S One,2012(9):e45825.
• [15]Pei YF,Lei Y,Liu XQ.MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1[J].Biochim Biophys Acta,2016(11):2177-2185.
• [16]Li P,Ma L,Zhang Y,et al.MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation[J].Biomed Pharmacother,2014(1):7-12.
• [17]Han Y,Bi Y,Bi H,et al.miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting Ct BP1[J].Hum Cell,2016(1):30-36.
• [18]Oberg AL,French AJ,Sarver AL,et al.miRNA expression in colon polyps provides evidence for a multihit model of colon cancer[J].PLo S One,2011(6):e20465.
• [19]Jiang J,Yu C,Chen M,et al.Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype[J].Oncotarget,2015(5):2767-2778.
• [20]Huang ZM,Yang J,Shen XY,et al.MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer[J].J Dig Dis,2009(3):188-194.
• [21]Chung HW,Wen Y,Choi EA,et al.Pleiotrophin(PTN)and midkine(MK)mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis[J].Mol Hum Reprod,2002(4):350-355.
• [22]Fu F,Xiao XI,Zhang T,et al.Expression of receptor protein tyrosine phosphatase zeta is a risk factor for triple negative breast cancer relapse[J].Biomed Rep,2016(2):167-172.
• [23]Chang X,Zhang H,Lian S,et al.miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A[J].Biochem Biophys Res Commun,2016(3):251-256.
• [24]Brownlie RJ,Garcia C,Ravasz M,et al.Resistance to TGF-beta suppression and improved anti-tumor responses in CD8+T cells lacking PTPN22[J].Nat Commun,2017(1):1343.
• [25]El-Badawy A,Ghoneim MA,Gabr MM,et al.Cancer cellsoluble factors reprogram mesenchymal stromal cells to slow cycling,chemoresistant cells with a more stem-like state[J].Stem Cell Res Ther,2017(1):254.

文章评论(Comment)：